<?xml version="1.0" encoding="UTF-8"?>
<p>In most patients, NAFLD is associated with features of metabolic syndrome, central obesity, elevated blood pressure, dyslipidemia, hyperglycemia, and insulin resistance [
 <xref rid="B29-nutrients-11-02601" ref-type="bibr">29</xref>]. Although these pathologies can be addressed by lifestyle interventions, in daily life the adherence to the necessary lifestyle changes is poor, resulting in suboptimal outcomes. In contrast, in pragmatic programs there is a greater benefit in a more substantial weight loss, particularly at early stages of the intervention period [
 <xref rid="B30-nutrients-11-02601" ref-type="bibr">30</xref>]. Hence, periodic fasting can significantly reduce weight, and this effect can be maintained over time [
 <xref rid="B31-nutrients-11-02601" ref-type="bibr">31</xref>]. 
</p>
